DISPOSITION OF CEFTRIAXONE (Ro 13-9904) IN RATS (I) BLOOD LEVEL PROFILES, TISSUE DISTRIBUTION AND EXCRETION OF 14C-CEFTRIAXONE
Blood level profile, tissue distribution and excretion of ceftriaxone (CTRX, Ro 13-9904), a new synthetic cephalosporin antibiotic, were examined in rats after a single intravenous injection of 14 C-ceftriaxone (14C-CTRX) at a dose of 20 mg/kg. 1. Blood level profile: A blood concentration of 14C-ra...
Saved in:
| Published in | CHEMOTHERAPY Vol. 32; no. Supplement7; pp. 136 - 147 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
Japanese Society of Chemotherapy
25.10.1984
|
| Online Access | Get full text |
| ISSN | 0009-3165 1884-5894 |
| DOI | 10.11250/chemotherapy1953.32.Supplement7_136 |
Cover
| Abstract | Blood level profile, tissue distribution and excretion of ceftriaxone (CTRX, Ro 13-9904), a new synthetic cephalosporin antibiotic, were examined in rats after a single intravenous injection of 14 C-ceftriaxone (14C-CTRX) at a dose of 20 mg/kg. 1. Blood level profile: A blood concentration of 14C-radioactivity was rapidly decreased over the first 4 hr after the i.v. injection (the level at the 4th hr was as low as 1/37 (male rats) 1/28 (female) of the 5-min level), while after the 4th hr, relatively slow decline curve was observed. The blood level of the intact drug represented a monophasic decline curve with a half time of 40 min between 30 min and 4 hr. 2. Tissue distribution: The highest 14C-radioactivity was observed in intestine (including its contents) and then in kidney and blood at each time point. The 14C-radioactivity in almost all the tissues examined was found to become lower with time, while the 14C in the intestine showed a peak level at the 6th hr postadministration. Elimination of 14C-radioactivity from kidney was somewhat slower when compared with the other tissues: approximately 20% of the 30-min radioactivity retained in this organ even after the 24th hr. 3. Excretion: During the initial 48 hr, nearly 40 and 50% of the dosed 14C were recovered in urine and bile, respectively, the latter was collected through a drainage inserted into the bile duct. About 90% of the radioactivity recovered in the initial 8-hr bile and in the 24-hr urine were associated with the intact drug itself. |
|---|---|
| AbstractList | Blood level profile, tissue distribution and excretion of ceftriaxone (CTRX, Ro 13-9904), a new synthetic cephalosporin antibiotic, were examined in rats after a single intravenous injection of 14 C-ceftriaxone (14C-CTRX) at a dose of 20 mg/kg. 1. Blood level profile: A blood concentration of 14C-radioactivity was rapidly decreased over the first 4 hr after the i.v. injection (the level at the 4th hr was as low as 1/37 (male rats) 1/28 (female) of the 5-min level), while after the 4th hr, relatively slow decline curve was observed. The blood level of the intact drug represented a monophasic decline curve with a half time of 40 min between 30 min and 4 hr. 2. Tissue distribution: The highest 14C-radioactivity was observed in intestine (including its contents) and then in kidney and blood at each time point. The 14C-radioactivity in almost all the tissues examined was found to become lower with time, while the 14C in the intestine showed a peak level at the 6th hr postadministration. Elimination of 14C-radioactivity from kidney was somewhat slower when compared with the other tissues: approximately 20% of the 30-min radioactivity retained in this organ even after the 24th hr. 3. Excretion: During the initial 48 hr, nearly 40 and 50% of the dosed 14C were recovered in urine and bile, respectively, the latter was collected through a drainage inserted into the bile duct. About 90% of the radioactivity recovered in the initial 8-hr bile and in the 24-hr urine were associated with the intact drug itself. |
| Author | TOMISAWA, HIROKI FUKAZAWA, HIDEO TAHARA, HITOSHI HEINTZ, R. TATEISHI, MITSURU ICHIHARA, SHIGEYASU |
| Author_xml | – sequence: 1 fullname: TOMISAWA, HIROKI organization: Nippon Roche Research Center – sequence: 1 fullname: ICHIHARA, SHIGEYASU organization: Nippon Roche Research Center – sequence: 1 fullname: TAHARA, HITOSHI organization: Nippon Roche Research Center – sequence: 1 fullname: TATEISHI, MITSURU organization: Nippon Roche Research Center – sequence: 1 fullname: HEINTZ, R. organization: F. Hoffmann-La Roche Co., Ltd – sequence: 1 fullname: FUKAZAWA, HIDEO organization: Nippon Roche Research Center |
| BookMark | eNpd0M1OwkAUBeCJwURE3mGWkFi8d6bztyQIOgmhhtbE3TgtU4FAadq64O010QVhdXIW5yy-e9KrTlUg5BFhgsgEPBXbcDx129D4-oxG8Alnk_S7rg_hGKpOOeTyhvRR6zgS2sQ90gcAE3GU4o4M23aXAyCCZJr1CX-26VuS2swmK5os6Gy-yNZ2-pGs5nS0PlHkkTEQj6ld0fU0S-nIjh_IbekPbRj-54C8L-bZ7DVaJi92Nl1Ge4xlFRWF0qiMKUCUkpnclEYjN3kA9Ip78EZtIN7oPPeBiQ1IiZ5JKYKKVYmB8wH5_Pvdt53_Cq5udkffnJ1vul1xCO4awnHmLiGu6q_LxdQ3LlT8B1cHY2k |
| ContentType | Journal Article |
| Copyright | Japanese Society of Chemotherapy |
| Copyright_xml | – notice: Japanese Society of Chemotherapy |
| DOI | 10.11250/chemotherapy1953.32.Supplement7_136 |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1884-5894 |
| EndPage | 147 |
| ExternalDocumentID | article_chemotherapy1953_32_Supplement7_32_Supplement7_136_article_char_en |
| GroupedDBID | 53G ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL DIK JSF JSH KQ8 RJT RZJ ZOHVM |
| ID | FETCH-LOGICAL-j146n-cc781799c05f629b9f98139be01a73a0a97d04d8bbae25d0661a2665e747f1e33 |
| ISSN | 0009-3165 |
| IngestDate | Wed Sep 03 06:25:56 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | Supplement7 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j146n-cc781799c05f629b9f98139be01a73a0a97d04d8bbae25d0661a2665e747f1e33 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/chemotherapy1953/32/Supplement7/32_Supplement7_136/_article/-char/en |
| PageCount | 12 |
| ParticipantIDs | jstage_primary_article_chemotherapy1953_32_Supplement7_32_Supplement7_136_article_char_en |
| PublicationCentury | 1900 |
| PublicationDate | 1984/10/25 |
| PublicationDateYYYYMMDD | 1984-10-25 |
| PublicationDate_xml | – month: 10 year: 1984 text: 1984/10/25 day: 25 |
| PublicationDecade | 1980 |
| PublicationTitle | CHEMOTHERAPY |
| PublicationTitleAlternate | Chemother. |
| PublicationYear | 1984 |
| Publisher | Japanese Society of Chemotherapy |
| Publisher_xml | – name: Japanese Society of Chemotherapy |
| References | 5) 山作房之輔, 金奮木康稔, 武田元, 関根理, 薄田芳丸: Ceftizoxime (CZX) の薬動力学的研究, 健康各ならひに腎機能障害者について. Chemotherapy28 (S-5): 338, 1980 8) 村川武雄, 坂本博, 深田志計美, 中本昭冶, 広瀬俊治, 伊藤位一, 西川実: Ceftizoxime (CZX) の実験動物における体内動態について. Chemotherapy 28 (S5): 111-118, 1980 6) 清水喜べ郎, 弁髪田子散平. 小出桂三: Cefoperazone (T-1551) の基礎的臨床的研究. Chemotherapy 28 (S-6): 390, 1980 2) PATEL, I. H.; S. CHEN, M. PARSONNET, M. R. HACK. MAN, NI. A. BROOKS, J. KONIKOFF & S. A. KAPLAN: Pharmacokinetics of ceftriaxone in humans. Antimicrob. Agents & Chemother. 20: 634-641, 1981 7) 真下啓明, 国井乙彦, 深谷一大, 大和邦雄, 里見信子, 笠井一弘, 重栖幹夫: Cefotaximeに関する基礎的臨床的検討. Chemotherapy 28 (S1): 194, 1980 9) 才川勇, 保田隆, 渡辺泰雄, 滝秀雄, 松原信之, 林敏雄, 松永清美, 高田理恵子: Cefoperazone (T-1551) の吸収・分布および排泄について. Chemotherapy 28 (S6): 163-172, 1980 1) SEDDON, M.; R. WISE, A. P. GILLETT & R. LIVING STON: Pharmacokinetics of Ro 13-9904, a broadspectrum cephalosporin. Antimicrob. Agents & Chemother. 18: 240-242, 1980 10) 荒谷春恵, 建石英樹, 祢宜田純子, 山中康光: Cefotaximeの体内動態に関する研究. Chemotherapy 28 (S-1): 65-72, 1980 3) STOECKEL, K.; P. J. MCNAMARA, R. BRANDT, H. PLOZZA-NOTTEBROCK & W. H. ZIEGLER The effects of concentration-dependent plasma protein binding on the phamacokinetics of ceftriaxone (Ro 13-9904), a new parenteral cephalosporin. Clin. Pharmacol. Ther. 29: 650-657, 1981 4) HEINTZ, R ; H. NOTTEBROCK, K. STOCKEL & R. BRANDT personal communication, 1979 |
| References_xml | – reference: 7) 真下啓明, 国井乙彦, 深谷一大, 大和邦雄, 里見信子, 笠井一弘, 重栖幹夫: Cefotaximeに関する基礎的臨床的検討. Chemotherapy 28 (S1): 194, 1980 – reference: 8) 村川武雄, 坂本博, 深田志計美, 中本昭冶, 広瀬俊治, 伊藤位一, 西川実: Ceftizoxime (CZX) の実験動物における体内動態について. Chemotherapy 28 (S5): 111-118, 1980 – reference: 10) 荒谷春恵, 建石英樹, 祢宜田純子, 山中康光: Cefotaximeの体内動態に関する研究. Chemotherapy 28 (S-1): 65-72, 1980 – reference: 4) HEINTZ, R ; H. NOTTEBROCK, K. STOCKEL & R. BRANDT personal communication, 1979 – reference: 9) 才川勇, 保田隆, 渡辺泰雄, 滝秀雄, 松原信之, 林敏雄, 松永清美, 高田理恵子: Cefoperazone (T-1551) の吸収・分布および排泄について. Chemotherapy 28 (S6): 163-172, 1980 – reference: 1) SEDDON, M.; R. WISE, A. P. GILLETT & R. LIVING STON: Pharmacokinetics of Ro 13-9904, a broadspectrum cephalosporin. Antimicrob. Agents & Chemother. 18: 240-242, 1980 – reference: 6) 清水喜べ郎, 弁髪田子散平. 小出桂三: Cefoperazone (T-1551) の基礎的臨床的研究. Chemotherapy 28 (S-6): 390, 1980 – reference: 5) 山作房之輔, 金奮木康稔, 武田元, 関根理, 薄田芳丸: Ceftizoxime (CZX) の薬動力学的研究, 健康各ならひに腎機能障害者について. Chemotherapy28 (S-5): 338, 1980 – reference: 2) PATEL, I. H.; S. CHEN, M. PARSONNET, M. R. HACK. MAN, NI. A. BROOKS, J. KONIKOFF & S. A. KAPLAN: Pharmacokinetics of ceftriaxone in humans. Antimicrob. Agents & Chemother. 20: 634-641, 1981 – reference: 3) STOECKEL, K.; P. J. MCNAMARA, R. BRANDT, H. PLOZZA-NOTTEBROCK & W. H. ZIEGLER The effects of concentration-dependent plasma protein binding on the phamacokinetics of ceftriaxone (Ro 13-9904), a new parenteral cephalosporin. Clin. Pharmacol. Ther. 29: 650-657, 1981 |
| SSID | ssib001106282 ssj0000626693 ssib058492509 ssib005879733 ssib008506721 |
| Score | 1.2532527 |
| Snippet | Blood level profile, tissue distribution and excretion of ceftriaxone (CTRX, Ro 13-9904), a new synthetic cephalosporin antibiotic, were examined in rats after... |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 136 |
| Subtitle | BLOOD LEVEL PROFILES, TISSUE DISTRIBUTION AND EXCRETION OF 14C-CEFTRIAXONE |
| Title | DISPOSITION OF CEFTRIAXONE (Ro 13-9904) IN RATS (I) |
| URI | https://www.jstage.jst.go.jp/article/chemotherapy1953/32/Supplement7/32_Supplement7_136/_article/-char/en |
| Volume | 32 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | CHEMOTHERAPY, 1984/10/25, Vol.32(Supplement7), pp.136-147 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1884-5894 dateEnd: 19941231 omitProxy: true ssIdentifier: ssj0000626693 issn: 0009-3165 databaseCode: KQ8 dateStart: 19530101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1884-5894 dateEnd: 20041231 omitProxy: true ssIdentifier: ssj0000626693 issn: 0009-3165 databaseCode: DIK dateStart: 19530101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcBWKhLggECAeBfnAoVVwsL1-7B6tyMFLlRhsR6Qny2uvD5FIqyo5lH_kn5j1-rEtHAqCi-V4tSOPZzKvnQdC7yxh1bJLueng0jdd3lgm9QkFQw7XDQF7wyvlie5y5cdr99PG20wmP7SspcOez6rvv60r-RuqwjOgq6yS_QPKDkDhAdwDfeEKFIbrnWgsUz-SjLWDc5LFdB4t8pSFm2QVqcjA1MYm6AFXuv5sNU3DPGstyt797zsUxNEyyeMoDT8Phm2eLFkWfg1b1cTS5GyIrrJ5zOIwbVeymH2MzkE0D9vCfilmeQLL40IeydhYG4BlebZO12PAwabElZJaFScrZQBKXA7HHNJK27QR8a0rGLu-IW0pyHg1C2ImlIAlANAjarBxL4HHCOdBVsBcdpnzgSZYbexrOtpWXTp_Ff9g0AHRKu115DHhDDszDWwxALvRaLsjY3F7d4GdQt996ycAK8at5RUw5j103wElIyeJnH3RDiVtWbCqdUcjAQ00a1s2D9S61YFpSAEfOoQMYbfv02E2oPyyD9D7Hu8Pd8AazKwtOB19wmJrQ-WP0aPO-TFChccTNNmWTxHWuNhIFobGxcZJemF0PHxqsJUhOdg4YafP0HoR5fPY7EZ5mFtQxTuzqgIiew9Wltf4DuW0oQR8Dy4suwxwaZU0qC23JpyXwvFqsIPtEpD1BHi7jS0wfo6Odhc78QIZ4HJwTCpXYIu7pR9wp8KiCfya1H7duM1LdK5wLC5Vv5bi3xH21X-E_Ro9HP9tx-hof3UQb8Dg3fO3LRv9BJr7oFs |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DISPOSITION+OF+CEFTRIAXONE+%28Ro+13-9904%29+IN+RATS+%28I%29&rft.jtitle=CHEMOTHERAPY&rft.au=TOMISAWA%2C+HIROKI&rft.au=ICHIHARA%2C+SHIGEYASU&rft.au=TAHARA%2C+HITOSHI&rft.au=TATEISHI%2C+MITSURU&rft.date=1984-10-25&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=32&rft.issue=Supplement7&rft.spage=136&rft.epage=147&rft_id=info:doi/10.11250%2Fchemotherapy1953.32.Supplement7_136&rft.externalDocID=article_chemotherapy1953_32_Supplement7_32_Supplement7_136_article_char_en |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon |